Title 40, Part 798 — Health Effects Testing Guidelines
27 sections
Section 798.2250
Dermal toxicity.
Section 798.2450
Inhalation toxicity.
Section 798.2650
Oral toxicity.
Section 798.3260
Chronic toxicity.
Section 798.3300
Oncogenicity.
Section 798.3320
Combined chronic toxicity/oncogenicity.
Section 798.4100
Dermal sensitization.
Section 798.4350
Inhalation developmental toxicity study.
Section 798.4700
Reproduction and fertility effects.
Section 798.4900
Developmental toxicity study.
Section 798.5195
Mouse biochemical specific locus test.
Section 798.5200
Mouse visible specific locus test.
Section 798.5265
The salmonella typhimurium reverse mutation assay.
Section 798.5275
Sex-linked recessive lethal test in drosophila melanogaster.
Section 798.5300
Detection of gene mutations in somatic cells in culture.
Section 798.5375
In vitro mammalian cytogenetics.
Section 798.5385
In vivo mammalian bone marrow cytogenetics tests: Chromosomal analysis.
Section 798.5395
In vivo mammalian bone marrow cytogenetics tests: Micronucleus assay.
Section 798.5450
Rodent dominant lethal assay.
Section 798.5460
Rodent heritable translocation assays.
Section 798.5500
Differential growth inhibition of repair proficient and repair deficient bacteria: “Bacterial DNA damage or repair tests.”
Section 798.5955
Heritable translocation test in drosophila melanogaster.
Section 798.6050
Functional observational battery.
Section 798.6200
Motor activity.
Section 798.6400
Neuropathology.
Section 798.6500
Schedule-controlled operant behavior.
Section 798.6560
Subchronic delayed neuro-toxicity of organophosphorus substances.